A venture capital fund injects money into its investments, but its mission doesn’t stop there. It accompanies the management of start-ups at every strategic stage and opens its address book to help them find talent and partners.
But some have chosen to go further, creating companies from academic programs and patents, piloting the start-ups themselves in the seed phase and forging partnerships as soon as the projects are launched.
This model is not totally new, but it is enjoying growing success. And several new “start-up studios” have been launched on the European life sciences venture capital scene.
Our guests will share their stories and experiences with us. They will explain the issues underlying this new approach to early-stage investing, as well as their ambitions and the risks they identify.
Relive the event
We'd love to get to know you
Join us, we offer you an extraordinary chance to learn, to develop and to be part of an exciting experience and team.Tell us your story